Corrigendum: Pyroglutamyl aminopeptidase 1 is a potential molecular target toward diagnosing and treating inflammation

Front Immunol. 2024 Dec 19:15:1538819. doi: 10.3389/fimmu.2024.1538819. eCollection 2024.

Authors

Hongfei Jiang¹, Qiuyu Gong², Renshuai Zhang¹

Affiliations

¹ The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao, China.
² Department of Thoracic Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2023.1301539.].

Keywords: anti-inflammatory therapy; biomarker; cancer; inflammation; pyroglutamyl aminopeptidase 1 (PGP-1).

Copyright © 2024 Jiang, Gong and Zhang.

Publication types

Published Erratum